CHICAGO--(BUSINESS WIRE)--CytoCore, Inc. (OTCBB:CYCR) – Dr. George Gorodeski, scientific advisory board director at CytoCore Inc., has identified the unique protein P2X7 biomarker as a highly accurate early indicator of uterine, endometrial and cervical cancer, as reported in the October issue of the American Association Cancer Research journal “Cancer Epidemiology Biomarkers & Prevention.”
